Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness
H-J. Blaheta(University of Tübingen), Claus Garbe(University Children's Hospital Tübingen), Burkhard Bueltmann(University of Tübingen), Karl Sotlar(University of Tübingen), Thomas A. Paul(Pfizer (United States)), A. Paul, Evelyn Maczey, Birgit Schittek(Hertie Institute for Clinical Brain Research), Matthias Moehrle, Helmut Breuninger, G. Rassner
Cited by 50
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
|The Lancet Oncology|2014|978
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
|The Oncologist|2011|579